{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:46:37Z","timestamp":1792554397697,"version":"4.5.0"},"reference-count":52,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["22H03283"],"award-info":[{"award-number":["22H03283"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["21K09980"],"award-info":[{"award-number":["21K09980"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["20K18607"],"award-info":[{"award-number":["20K18607"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The pathophysiology, pathogenesis, histopathology, and immunopathology of medication-related osteonecrosis of the jaw (MRONJ) Stage 0 remain unclear, although 50% of MRONJ Stage 0 cases could progress to higher stages. The aim of this study was to investigate the effects of zoledronate (Zol) and anti-vascular endothelial cell growth factor A (VEGFA) neutralizing antibody (Vab) administration on polarization shifting of macrophage subsets in tooth extraction sockets by creating a murine model of MRONJ Stage 0-like lesions. Eight-week-old, female C57BL\/6J mice were randomly divided into 4 groups: Zol, Vab, Zol\/Vab combination, and vehicle control (VC). Subcutaneous Zol and intraperitoneal Vab administration were performed for 5 weeks with extraction of both maxillary first molars 3 weeks after drug administration. Euthanasia was conducted 2 weeks after tooth extraction. Maxillae, tibiae, femora, tongues, and sera were collected. Structural, histological, immunohistochemical, and biochemical analyses were comprehensively performed. Tooth extraction sites appeared to be completely healed in all groups. However, osseous healing and soft tissue healing of tooth extraction sites were quite different. The Zol\/Vab combination significantly induced abnormal epithelial healing, and delayed connective tissue healing due to decreased rete ridge length and thickness of the stratum granulosum and due to decreased collagen production, respectively. Moreover, Zol\/Vab significantly increased necrotic bone area with increased numbers of empty lacunae compared with Vab and VC. Most interestingly, Zol\/Vab significantly increased the number of CD169+ osteal macrophages (osteomacs) in the bone marrow and decreased F4\/80+ macrophages, with a slightly increased ratio of F4\/80+CD38+ M1 macrophages compared to VC. These findings are the first to provide new evidence of the involvement of osteal macrophages in the immunopathology of MRONJ Stage 0-like lesions.<\/jats:p>","DOI":"10.3390\/jcm12051914","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T06:09:52Z","timestamp":1677564592000},"page":"1914","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Zoledronate\/Anti-VEGF Neutralizing Antibody Combination Administration Increases Osteal Macrophages in a Murine Model of MRONJ Stage 0-like Lesions"],"prefix":"10.3390","volume":"12","author":[{"given":"Haruka","family":"Kaneko","sequence":"first","affiliation":[{"name":"Department of Applied Prosthodontics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9891-9987","authenticated-orcid":false,"given":"Shinichiro","family":"Kuroshima","sequence":"additional","affiliation":[{"name":"Department of Applied Prosthodontics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Kozutsumi","sequence":"additional","affiliation":[{"name":"Department of Applied Prosthodontics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2747-6423","authenticated-orcid":false,"given":"Farah A.","family":"Al-Omari","sequence":"additional","affiliation":[{"name":"Department of Applied Prosthodontics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Hayano","sequence":"additional","affiliation":[{"name":"Department of Applied Prosthodontics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Applied Prosthodontics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sawase","sequence":"additional","affiliation":[{"name":"Department of Applied Prosthodontics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"ref_1","first-page":"1016","article-title":"Clinical trials referral resource: Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab","volume":"15","author":"Chen","year":"2001","journal-title":"Oncology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13045-021-01213-z","article-title":"Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990\u20132019","volume":"14","author":"Lin","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws\u20142022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e23500","DOI":"10.1002\/dvg.23500","article-title":"Medication-related osteonecrosis of the jaw: A literature review and update","volume":"60","author":"Kuroshima","year":"2022","journal-title":"Genesis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-010-0866-3","article-title":"Bevacizumab and osteonecrosis of the jaw: Incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer","volume":"122","author":"Guarneri","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4049\/jimmunol.181.2.1232","article-title":"Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo","volume":"181","author":"Chang","year":"2008","journal-title":"J. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/bloodadvances.2017011304","article-title":"Osteomacs interact with megakaryocytes and osteoblasts to regulate murine hematopoietic stem cell function","volume":"1","author":"Mohamad","year":"2017","journal-title":"Blood Adv."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/jbmr.354","article-title":"Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model","volume":"26","author":"Alexander","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1073\/pnas.1315153111","article-title":"Osteal macrophages support physiologic skeletal remodeling and anabolic actions of parathyroid hormone in bone","volume":"111","author":"Cho","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1016\/j.ajpath.2014.08.017","article-title":"Fracture healing via periosteal callus formation requires macrophages for both initiation and progression of early endochondral ossification","volume":"184","author":"Raggatt","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.biomaterials.2017.10.033","article-title":"CD169+ macrophages are critical for osteoblast maintenance and promote intramembranous and endochondral ossification during bone repair","volume":"196","author":"Batoon","year":"2019","journal-title":"Biomaterials"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00784-020-03602-z","article-title":"The role of M1 and M2 macrophage polarization in progression of medication-related osteonecrosis of the jaw","volume":"25","author":"Paschalidi","year":"2021","journal-title":"Clin. Oral Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"115942","DOI":"10.1016\/j.bone.2021.115942","article-title":"Alendronate\/dexamethasone combination therapy worsens soft and hard tissue wound healing around implants in rat maxillae","volume":"148","author":"Inoue","year":"2021","journal-title":"Bone"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"115308","DOI":"10.1016\/j.bone.2020.115308","article-title":"Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice","volume":"135","author":"Hayano","year":"2020","journal-title":"Bone"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"115560","DOI":"10.1016\/j.bone.2020.115560","article-title":"Dynamic polarization shifting from M1 to M2 macrophages in reduced osteonecrosis of the jaw-like lesions by cessation of anti-RANKL antibody in mice","volume":"141","author":"Tamaki","year":"2020","journal-title":"Bone"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10354-016-0437-2","article-title":"Position paper on medication-related osteonecrosis of the jaw (MRONJ)","volume":"166","author":"Svejda","year":"2016","journal-title":"Wien. Med. Wochenschr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.11005\/jbm.2021.28.4.279","article-title":"Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons","volume":"28","author":"Kim","year":"2021","journal-title":"J. Bone Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00774-016-0810-7","article-title":"Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw","volume":"35","author":"Yoneda","year":"2017","journal-title":"J. Bone Miner. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","article-title":"Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: A case series","volume":"123","author":"Fedele","year":"2010","journal-title":"Am. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00223-021-00890-9","article-title":"Zoledronic Acid Deteriorates Soft and Hard Tissue Healing of Murine Tooth Extraction Sockets in a Dose-Dependent Manner","volume":"110","author":"Kozutsumi","year":"2022","journal-title":"Calcif. Tissue Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00774-017-0872-1","article-title":"Effect of anti-angiogenesis induced by chemotherapeutic monotherapy, chemotherapeutic\/bisphosphonate combination therapy and anti-VEGFA mAb therapy on tooth extraction socket healing in mice","volume":"36","author":"Akita","year":"2018","journal-title":"J. Bone Miner. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jbmr.3292","article-title":"Transplantation of Noncultured Stromal Vascular Fraction Cells of Adipose Tissue Ameliorates Osteonecrosis of the Jaw-Like Lesions in Mice","volume":"33","author":"Kuroshima","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bone.2018.05.001","article-title":"Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice","volume":"112","author":"Kuroshima","year":"2018","journal-title":"Bone"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"45826","DOI":"10.1074\/jbc.M309024200","article-title":"Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity","volume":"278","author":"Peyruchaud","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood.V97.3.785","article-title":"Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans","volume":"97","author":"Sawano","year":"2001","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-5793(00)01520-9","article-title":"Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts","volume":"473","author":"Nakagawa","year":"2000","journal-title":"FEBS Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Nihal","year":"2008","journal-title":"FASEB J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: Relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Biguetti, C.C., De Oliva, A.H., Healy, K., Mahmoud, R.H., Cust\u00f3dio, I.D.C., Constantino, D.H., Ervolino, E., Duarte, M.A.H., Fakhouri, W.D., and Matsumoto, M.A. (2019). Medication-related osteonecrosis of the jaws after tooth extraction in senescent female mice treated with zoledronic acid: Microtomographic, histological and immunohistochemical characterization. PLoS ONE, 14.","DOI":"10.1101\/574111"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"19535","DOI":"10.1038\/s41598-021-98713-2","article-title":"Alveolar socket healing in 5-lipoxygenase knockout aged female mice treated or not with high dose of zoledronic acid","volume":"11","author":"Mahmoud","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.job.2019.03.005","article-title":"Medication-related osteonecrosis of the jaw: A literature review","volume":"61","author":"Kuroshima","year":"2019","journal-title":"J. Oral Biosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates\u2013histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J. Oral Pathol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation?","volume":"45","author":"Lesclous","year":"2009","journal-title":"Bone"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/1078-0432.CCR-07-1430","article-title":"Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw","volume":"14","author":"Raje","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_39","first-page":"6651318","article-title":"Comparison of Vascular Morphometry in Jawbones and Long Bones: Micro-CT Study in a Rat Model Treated with Zoledronic Acid","volume":"2021","author":"Wang","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"151703","DOI":"10.1016\/j.aanat.2021.151703","article-title":"Podosome formation in the murine palatal mucosae: Its proteolytic role in rete peg formation","volume":"235","author":"Chen","year":"2021","journal-title":"Ann. Anat."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10735-021-10016-y","article-title":"Regulatory mechanism of oral mucosal rete peg formation","volume":"52","author":"Chen","year":"2021","journal-title":"J. Mol. Histol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fimmu.2019.00208","article-title":"Oral Mucosal Epithelial Cells","volume":"10","author":"Groeger","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1749-6632.2012.06504.x","article-title":"Diverse types of junctions containing tight junction proteins in stratified mammalian epithelia","volume":"1257","author":"Franke","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0765.2006.00875.x","article-title":"Expression pattern of adhesion molecules in junctional epithelium differs from that in other gingival epithelia","volume":"41","author":"Hatakeyama","year":"2006","journal-title":"J. Periodontal Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13287-019-1308-8","article-title":"Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice","volume":"10","author":"Kuroshima","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/jbmr.4413","article-title":"Osteal macrophages support osteoclast-mediated resorption and contribute to bone pathology in a postmenopausal osteoporosis mouse model","volume":"36","author":"Batoon","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"664871","DOI":"10.3389\/fimmu.2021.664871","article-title":"The Macrophage-Osteoclast Axis in Osteoimmunity and Osteo-Related Diseases","volume":"12","author":"Yao","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e13032","DOI":"10.1111\/acel.13032","article-title":"Skewed macrophage polarization in aging skeletal muscle","volume":"18","author":"Cui","year":"2019","journal-title":"Aging Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/gutjnl-2016-312940","article-title":"Age-dependent shift in macrophage polarization causes inflammation-mediated degeneration of enteric nervous system","volume":"67","author":"Becker","year":"2018","journal-title":"Gut"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s40883-016-0016-5","article-title":"Aging Affects Bone Marrow Macrophage Polarization: Relevance to Bone Healing","volume":"2","author":"Gibon","year":"2016","journal-title":"Regen. Eng. Transl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41420-021-00797-2","article-title":"Autophagy deficiency promotes M1 macrophage polarization to exacerbate acute liver injury via ATG5 repression during aging","volume":"7","author":"Liu","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/jir.2011.0058","article-title":"Advanced age impairs macrophage polarization","volume":"32","author":"Mahbub","year":"2012","journal-title":"J. Interferon Cytokine Res."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/5\/1914\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:44:03Z","timestamp":1760121843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/5\/1914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["jcm12051914"],"URL":"https:\/\/doi.org\/10.3390\/jcm12051914","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]}}}